According to a new study, tildrakizumab is linked to improved quality of life (QoL) and sleep in patients with moderate-to-severe plaque psoriasis.
top of page
it's where dermatology lives
bottom of page
According to a new study, tildrakizumab is linked to improved quality of life (QoL) and sleep in patients with moderate-to-severe plaque psoriasis.
Commenti